Get proactive, long term care: Extend remission and stay ahead of recurrence

We detect early signs of cancer recurrence or progression months before scans, identify specific disease drivers, and recommend evidence-based, targeted, personalized treatments

Book a complementary introductory call with our team below.

Required

Required

Required

Required

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
"Astron found 5 personalized treatment options for my clinician and I with the relevant research and evidence."
Judith - Astron Patient
Our team have led teams and studied at some of the world's top research organisations

How we target the drivers of recurrence, tolerably

Molecular tests can identify 1000s of mutations, but conventional precision oncology only targets fewer than 50 of these, limiting its ability to target the drivers of recurrence. Our bioinformatic drug repurposing research lets us match 40x more drivers than current precision oncology. Our treatment recommendations are peer reviewed, well understood and highly tolerable, so they are well suited for use in remission.

Uncover the drivers of recurrence and progression

Find the treatment options to target them - {full_price_value}.

For total peace of mind sign up to our monitoring service once your initial test is completed.
Monitoring includes consultations with an expert at least every quarter and adjustments to treatments based on test results and changes in your condition.

What patients are saying about Astron

"With these treatments I've got optionality and that makes a huge difference psychologically"

Paul

Astron Patient

"Practically tackling issues specific to my cancer has quite simply been life changing"

Judith

Astron Patient

"I've taken control in some way, you know. I want to know I've ticked every box."

Carol

Astron Patient

How Astron Works

Molecular Analysis

We conduct testing to identify the drivers that put you at risk of recurrence or progression.

1
2
Targeted Treatment Planning

We use bioinformatics to match treatments to the specific drivers in your cancer.

Quarterly Monitoring

We test for Molecular Residual Disease to detect tumour cells before they are visible on scans, and meet you to talk through the results.

3
4
Treatment Adaptation

We adjust the personalized treatment protocol based on test results to optimize your treatment.

Still want to learn more?

Read our articles on precision oncology, our research and our mission.

Read Our Blog